OBJECTIVE: To understand the clinicopathological features of @entity43 and evaluate the significance of various histological appearances. METHODS: Forty-five @entity1 with @entity5 were analyzed retrospectively. The stage distribution was stage I, 34 @entity1 , stage II, 4 @entity1 and stage III, 7 @entity1 . RESULTS: Forty-five cases of @entity5 accounted for 25.4% of @entity43 . The ratio of serous @entity5 (SBTs) to mucinous @entity5 (MBTs) was approximately 1:1.3. Nine of eleven SBTs with exophytic growth presented peritoneal implants, of which two were invasive and seven noninvasive. Two SBTs and 1 MBT recurred after 5, 4, and 1 years respectively. Thirty-three cases were followed from 2 to 9 years. The 5-year survival rate was 100% (Kaplan-Meir method). CONCLUSIONS: The prognosis of the SBTs is favorable. SBTs with exophytic growth are often associated with peritoneum implants.

[Clinicopathologic analysis of ovarian serous and mucinous XXXX ].

@entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian borderline tumors', 'ovarian epithelial malignant tumors'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['borderline tumors']
@entity5 :: (MESH:D009369,Disease) :: ['borderline tumors']
